Sperm cryopreservation best practices prior to gonadotoxic treatment: Recommendations from leaders in fertility preservation. Read more about Sperm cryopreservation best practices prior to gonadotoxic treatment: Recommendations from leaders in fertility preservation.
PREGNANCY-INDUCED HYPERTENSION (PIH) AND THE NUMBER OF CORPUS LUTEA IN EARLY PREGNANCY. Read more about PREGNANCY-INDUCED HYPERTENSION (PIH) AND THE NUMBER OF CORPUS LUTEA IN EARLY PREGNANCY.
HYPERTENSIVE DISORDERS OF PREGNANCY (HDP) IN PATIENTS WITH UNDERLYING INFERTILITY. Read more about HYPERTENSIVE DISORDERS OF PREGNANCY (HDP) IN PATIENTS WITH UNDERLYING INFERTILITY.
A SLOWER HUMAN CHORIONIC GONADOTROPIN (HCG) RISE IN EARLY PREGNANCY WAS NOT ASSOCIATED WITH THE DEVELOPMENT OF ABNORMAL PLACENTATION IN PATIENTS WHO CONCEIVED USING ASSISTED REPRODUCTIVE TECHNOLOGY. Read more about A SLOWER HUMAN CHORIONIC GONADOTROPIN (HCG) RISE IN EARLY PREGNANCY WAS NOT ASSOCIATED WITH THE DEVELOPMENT OF ABNORMAL PLACENTATION IN PATIENTS WHO CONCEIVED USING ASSISTED REPRODUCTIVE TECHNOLOGY.
EFFECTS OF ASSISTED REPRODUCTIVE TECHNOLOGY (ART) ON MATERNAL SERUM ANALYTES IN AN INFERTILE PATIENT POPULATION. Read more about EFFECTS OF ASSISTED REPRODUCTIVE TECHNOLOGY (ART) ON MATERNAL SERUM ANALYTES IN AN INFERTILE PATIENT POPULATION.
Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled n Read more about Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled n
One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America. Read more about One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America.
Male vitamin D status and male factor infertility. Read more about Male vitamin D status and male factor infertility.
Development and validation of a novel mail-in semen analysis system and the correlation between one hour and delayed semen analysis testing. Read more about Development and validation of a novel mail-in semen analysis system and the correlation between one hour and delayed semen analysis testing.
The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Read more about The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial.
